{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:01:50Z","timestamp":1781798510067,"version":"3.54.5"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111306","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T09:47:01Z","timestamp":1701337621000},"page":"111306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome"],"prefix":"10.1016","volume":"126","author":[{"given":"Sara","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rezaieyazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Shapouri-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh Lavi","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh Sadat","family":"Tabasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-4170","authenticated-orcid":false,"given":"Seyed-Alireza","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.111306_b0005","first-page":"1053","volume":"Vol. 27","author":"Fathollahi","year":"2018","journal-title":"Mesenchymal Stem Cell Transplantation in Systemic Lupus Erythematous, a Mesenchymal Stem Cell Disorder"},{"key":"10.1016\/j.intimp.2023.111306_b0010","doi-asserted-by":"crossref","unstructured":"Tsokos GC. Mechanisms of Disease Systemic Lupus Erythematosus. Vol. 22, n engl j med. 2011.","DOI":"10.1056\/NEJMra1100359"},{"key":"10.1016\/j.intimp.2023.111306_b0015","doi-asserted-by":"crossref","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. Vol. 16, World Journal of Pediatrics. Institute of Pediatrics of Zhejiang University; 2020. p. 19\u201330.","DOI":"10.1007\/s12519-019-00229-3"},{"key":"10.1016\/j.intimp.2023.111306_b0020","first-page":"2366","volume":"Vol. 72","author":"Radmanesh","year":"2020","journal-title":"The Immunomodulatory Effects of Mesenchymal Stromal Cell-Based Therapy in Human and Animal Models of Systemic Lupus Erythematosus"},{"issue":"2","key":"10.1016\/j.intimp.2023.111306_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2023.111306_b0030","doi-asserted-by":"crossref","unstructured":"Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Vol. 12, Nature Reviews Rheumatology. Nature Publishing Group; 2011, p. 716\u201330.","DOI":"10.1038\/nrrheum.2016.186"},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22631\/rr.2017.69997.1010","article-title":"Cytokines in systemic lupus erythematosus: their role in pathogenesis of disease and possible therapeutic opportunities","volume":"2","author":"Tahernia","year":"2017","journal-title":"Rheumatol. Res."},{"key":"10.1016\/j.intimp.2023.111306_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/347141","article-title":"Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE","volume":"2012","author":"Su","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2023.111306_b0045","article-title":"Cytokine networks in systemic lupus erythematosus","volume":"2010","author":"Nishimoto","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"10","key":"10.1016\/j.intimp.2023.111306_b0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/jir.2011.0047","article-title":"The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus","volume":"31","author":"Davis","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.intimp.2023.111306_b0055","doi-asserted-by":"crossref","unstructured":"E.A. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, A. Marshak-Rothstein, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors [Internet]. 2002. Available from: www.nature.com.","DOI":"10.1038\/416603a"},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0060","article-title":"Inhibition of IL-17 ameliorates systemic lupus erythematosus in Roquin san\/san mice through regulating the balance of TFH cells, GC B cells, Treg and Breg","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.111306_b0065","doi-asserted-by":"crossref","unstructured":"M.L. Bertolaccini, S. Sciascia, M. Radin, D. Roccatello, G. Sanna, Recent advances in the management of systemic lupus erythematosus [version 1; referees: 2 approved]. Vol. 7, F1000Research. F1000 Research Ltd; 2018.","DOI":"10.12688\/f1000research.13941.1"},{"issue":"12","key":"10.1016\/j.intimp.2023.111306_b0070","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1002\/jcb.26155","article-title":"Vitamin D3 Alters the Expression of Toll-like Receptors in Peripheral Blood Mononuclear Cells of Patients With Systemic Lupus Erythematosus","volume":"118","author":"Yazdanpanah","year":"2017","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.intimp.2023.111306_b0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","article-title":"Curcumin: A natural modulator of immune cells in systemic lupus erythematosus","volume":"17","author":"Momtazi-Borojeni","year":"2018","journal-title":"Autoimmunity Rev."},{"key":"10.1016\/j.intimp.2023.111306_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaci.2010.12.1087","article-title":"Current and novel therapeutics in the treatment of systemic lupus erythematosus","volume":"127","author":"Yildirim-Toruner","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.111306_b0085","article-title":"Tolerising cellular therapies: What is their promise for autoimmune disease?","author":"Mosanya","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2023.111306_b0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/0961203320928419","article-title":"Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus","volume":"29","author":"Liu","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2023.111306_b0095","unstructured":"J. Liang, L. Sun, SPECIAL ISSUE ON LUPUS IN ASIA-PACIFIC REGION Mesenchymal stem cells transplantation for systemic lupus erythematosus. 2014."},{"issue":"13","key":"10.1016\/j.intimp.2023.111306_b0100","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1177\/0961203318804922","article-title":"Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis","volume":"27","author":"Barbado","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2023.111306_b0105","volume":"Volume 37","author":"Dixon","year":"1985"},{"key":"10.1016\/j.intimp.2023.111306_b0110","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-12-394596-9.00010-X","article-title":"Animal models of molecular pathology: Systemic lupus erythematosus","author":"Sang","year":"2012"},{"key":"10.1016\/j.intimp.2023.111306_b0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2023.111306_b0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrrheum.2010.63","article-title":"Genetics of SLE: Evidence from mouse models","volume":"6","author":"Morel","year":"2010","journal-title":"Nature Rev. Rheumatology"},{"issue":"11","key":"10.1016\/j.intimp.2023.111306_b0125","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","article-title":"Pristane-induced lupus: considerations on this experimental model","volume":"36","author":"Freitas","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16999-7","article-title":"A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice \/631\/250\/38 \/631\/250\/256\/2515 \/13\/21 article","volume":"7","author":"Gunawan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.111306_b0135","doi-asserted-by":"crossref","unstructured":"M.F. Shaikh, N. Jordan, D.P. D\u2019cruz, CMJv17n1-CME_Shaikh.indd. Vol. 17, CME RHEUMATOLOGY Clinical Medicine. 2017.","DOI":"10.7861\/clinmedicine.17-1-78"},{"key":"10.1016\/j.intimp.2023.111306_b0140","first-page":"117","article-title":"Dysregulated balance in Th17\/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?","volume":"1","author":"Hoseinzadeh","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.111306_b0145","first-page":"1183","volume":"Vol. 41","author":"Neonaki","year":"2021","journal-title":"Acute Liver Injury as Initial Manifestation of Systemic Lupus Erythematosus-Induced Myocarditis"},{"issue":"11","key":"10.1016\/j.intimp.2023.111306_b0150","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3899\/jrheum.080336","article-title":"Liver involvement in systemic lupus erythematosus: Case review of 40 patients","volume":"35","author":"Chowdhary","year":"2008","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12878-016-0042-z","article-title":"Hypersplenism in liver disease and SLE revisited: Current evidence supports an active rather than passive process","volume":"16","author":"Gemery","year":"2016","journal-title":"BMC Hematol."},{"key":"10.1016\/j.intimp.2023.111306_b0160","first-page":"197","volume":"Vol. 508","author":"dos Santos","year":"2020","journal-title":"Uric Acid and Kidney Damage in Systemic Lupus Erythematosus"},{"issue":"6","key":"10.1016\/j.intimp.2023.111306_b0165","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1002\/jcp.27663","article-title":"Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model","volume":"234","author":"Khorasani","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2023.111306_b0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrneph.2012.220","article-title":"Diagnosis and treatment of lupus nephritis flares - An update","volume":"8","author":"Sprangers","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2023.111306_b0175","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.4049\/jimmunol.170.9.4818","article-title":"Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis","volume":"170","author":"Singh","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.111306_b0180","volume":"Vol. 9","author":"Howe","year":"2020"},{"issue":"3","key":"10.1016\/j.intimp.2023.111306_b0185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","article-title":"A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem\/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus","volume":"10","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"9","key":"10.1016\/j.intimp.2023.111306_b0190","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3727\/096368911X582769","article-title":"Stem cell transplantation in amyotrophic lateral sclerosis patients: Methodological approach, safety, and feasibility","volume":"21","author":"Mart\u00ednez","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.intimp.2023.111306_b0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1586\/1744666X.2015.1037741","article-title":"Stem cell therapies for systemic lupus erythematosus: Current progress and established evidence","volume":"11","author":"Wang","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.111306_b0200","volume":"Vol. 7","author":"Cheng","year":"2019"},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0205","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02357-y","article-title":"Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia","volume":"12","author":"Qi","year":"2021","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0210","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jcp.26819","article-title":"In vivo study: Th1\u2013Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics","volume":"234","author":"Mardani","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.intimp.2023.111306_b0215","doi-asserted-by":"crossref","unstructured":"M. Potter, J.S. Wax, Genetics of susceptibility to pristane-induced plasmacytomas in BALB\/cAn: reduced susceptibility in BALB\/cJ with a brief description of pristane-induced arthritis. The Journal of Immunology [Internet]. 127(4) (1981) 1591. Available from: http:\/\/www.jimmunol.org\/content\/127\/4\/1591.abstract.","DOI":"10.4049\/jimmunol.127.4.1591"},{"issue":"7","key":"10.1016\/j.intimp.2023.111306_b0220","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.0800771","article-title":"B Cell Proliferation, Somatic Hypermutation, Class Switch Recombination, and Autoantibody Production in Ectopic Lymphoid Tissue in Murine Lupus","volume":"182","author":"Nacionales","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42358-019-0072-x","article-title":"CD4+CD69+ T cells and CD4+CD25+FoxP3+ Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice","volume":"59","author":"Peixoto","year":"2019","journal-title":"Adv. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111306_b0230","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2023.111306_b0235","first-page":"6","article-title":"Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1\/Th2 ratios in a murine model of SLE","volume":"7","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.111306_b0240","first-page":"615","volume":"Vol. 23","author":"Moulton","year":"2017","journal-title":"Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective"},{"key":"10.1016\/j.intimp.2023.111306_b0245","volume":"Vol. 11","author":"Yu","year":"2021"},{"issue":"6","key":"10.1016\/j.intimp.2023.111306_b0250","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.7150\/ijms.51117","article-title":"Elevated creatinine clearance in lupus nephritis patients with normal creatinine","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci."},{"key":"10.1016\/j.intimp.2023.111306_b0255","unstructured":"Satoh M, Reeves WH. Induction of Lupus-associated Autoantibodies in BALB\/c Mice by Intraperitoneal Injection of Pristane."},{"key":"10.1016\/j.intimp.2023.111306_b0260","doi-asserted-by":"crossref","unstructured":"Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, et al. Transplantation of Human Bone Marrow Mesenchymal Stem Cell Ameliorates the Autoimmune Pathogenesis in MRL\/lpr Mice. Vol. 5, Cellular & Molecular Immunology 417 Article. 2008.","DOI":"10.1038\/cmi.2008.52"},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02586-1","article-title":"Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-\u03b21","volume":"12","author":"Chun","year":"2021","journal-title":"Stem Cell. Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.111306_b0270","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3727\/096368915X689442","article-title":"Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig-overproducing xenogeneic adipose tissue-derived mesenchymal stem cells on murine systemic lupus erythematosus","volume":"25","author":"Choi","year":"2016","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1538-9","article-title":"Efficacy of mesenchymal stem cells in animal models of lupus nephritis: A meta-analysis","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2023.111306_b0280","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s12026-016-8866-y","article-title":"Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus","volume":"64","author":"He","year":"2016","journal-title":"Immunol. Res."},{"issue":"10","key":"10.1016\/j.intimp.2023.111306_b0285","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.2147\/DDDT.S114501","article-title":"Methyl salicylate 2-O-\u03b2-D-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction","volume":"29","author":"He","year":"2016","journal-title":"Drug Des Dev. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2023.111306_b0290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.apsb.2016.07.001","article-title":"Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB\/c mice","volume":"7","author":"Lin","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2023.111306_b0295","article-title":"Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39\u2212CD73 signaling pathway","volume":"113","author":"Dang","year":"2020","journal-title":"J. Autoimmun. [internet]."},{"issue":"2","key":"10.1016\/j.intimp.2023.111306_b0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2012.08.012","article-title":"Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL\/lpr and (NZB\/NZW)F1 mice","volume":"145","author":"Gu","year":"2012","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.111306_b0305","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.4049\/jimmunol.1400036","article-title":"Impaired B Cell Inhibition by Lupus Bone Marrow Mesenchymal Stem Cells Is Caused by Reduced CCL2 Expression","volume":"193","author":"Che","year":"2014","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.intimp.2023.111306_b0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2018.05.034","article-title":"Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis","volume":"1","author":"Ma","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.111306_b0315","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri3173","article-title":"The molecular basis of the memory T cell response: Differential gene expression and its epigenetic regulation","volume":"12","author":"Weng","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.111306_b0320","volume":"Vol. 188","author":"Richards","year":"1998"},{"key":"10.1016\/j.intimp.2023.111306_b0325","doi-asserted-by":"crossref","unstructured":"Sun L, Liang J, Li H, Hou Y. Polarization of T Lymphocytes Is Regulated by Mesenchymal Stem Cells in NZBWF1 and BALB\/c Mice. Int J Mol Sci [Internet]. 2007 [cited 2022 Oct 31];8(5):455\u201369. Available from: http:\/\/www.mdpi.com\/1422-0067\/8\/5\/455.","DOI":"10.3390\/i8050455"},{"issue":"9","key":"10.1016\/j.intimp.2023.111306_b0330","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.27560","article-title":"Interferon-\u03b3-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus","volume":"62","author":"Schena","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2023.111306_b0335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.33313","article-title":"Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation","volume":"64","author":"Choi","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2023.111306_b0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0961203309348983","article-title":"Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients","volume":"19","author":"Carrion","year":"2010","journal-title":"Lupus"},{"issue":"13","key":"10.1016\/j.intimp.2023.111306_b0345","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/0961203310373782","article-title":"Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice","volume":"19","author":"Gu","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2023.111306_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02666","article-title":"Third-party allogeneic mesenchymal stromal cells prevent rejection in a pre-sensitized high-risk model of corneal transplantation","author":"Lohan","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111306_b0355","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3349\/ymj.2017.58.5.1031","article-title":"Immune tolerance of human dental pulp-derived mesenchymal stem cells mediated by CD4+CD25+ FoxP3+ regulatory T-cells and induced by TGF-\u03b21 and IL-10","volume":"58","author":"Hong","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"6","key":"10.1016\/j.intimp.2023.111306_b0360","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/scd.2011.0157","article-title":"The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population","volume":"21","author":"Svobodova","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"12","key":"10.1016\/j.intimp.2023.111306_b0365","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of Peripheral CD4+CD25- Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-\u03b2 Induction of Transcription Factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.111306_b0370","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/rheumatology\/ker116","article-title":"Recovery of the Immune Balance between Th17 and Regulatory T Cells as a Treatment for Systemic Lupus Erythematosus","volume":"50","author":"Yang","year":"2011","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.intimp.2023.111306_b0375","doi-asserted-by":"crossref","unstructured":"Rezalotfi A, Ahmadian E, Aazami H, Solgi G, Ebrahimi M. Gastric cancer stem cells effect on Th17\/Treg balance; a bench to beside perspective. Vol. 9, Frontiers in Oncology. Frontiers Media S.A.; 2019.","DOI":"10.3389\/fonc.2019.00226"},{"key":"10.1016\/j.intimp.2023.111306_b0380","unstructured":"Handono K, Hasanah D, Kalim H, Mawarti H. The associations among serum levels of vitamin D, TGF-\u03b2\/IL-6 balance and Treg\/Th17 balance in systemic lupus erythematosus patients in Indonesia [Internet]. Vol. 2, International Journal of Biochemistry and Biotechnology. 2013. Available from: www.internationalscholarsjournals.org."},{"issue":"3","key":"10.1016\/j.intimp.2023.111306_b0385","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21315\/mjms2018.25.3.3","article-title":"Regulatory T cells compensation failure cause the dysregulation of immune response in pristane induced lupus mice model","volume":"25","author":"Kalim","year":"2018","journal-title":"Malaysian J. Med. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.111306_b0390","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3727\/096368913X664577","article-title":"Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of Th1\/Th2 and Th17\/Treg cells in a murine acute graft-versus-host disease model","volume":"23","author":"Lim","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.intimp.2023.111306_b0395","doi-asserted-by":"crossref","unstructured":"Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, et al. The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol [Internet]. 14(5) (2017) 423\u2013431. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26435067\/.","DOI":"10.1038\/cmi.2015.89"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923016338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:15:21Z","timestamp":1761588921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923016338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":79,"alternative-id":["S1567576923016338"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111306","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111306"}}